Pathology Analysis & Statistics, January 2015 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

571-600 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

HealthSouth Corporation (Symbol:HLS) SWOT Analysis, Strategy, Revenues and Profits

HealthSouth Corporation (Symbol:HLS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Henan Lingrui Pharmaceutical Co., Ltd. (Symbol:600285) SWOT Analysis, Strategy, Revenues and Profits

Henan Lingrui Pharmaceutical Co., Ltd. (Symbol:600285) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Ina Research Inc. (Symbol:2176) SWOT Analysis, Strategy, Revenues and Profits

Ina Research Inc. (Symbol:2176) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Philippines, Japan
IsoRay, Inc. (Symbol:ISR) SWOT Analysis, Strategy, Revenues and Profits

IsoRay, Inc. (Symbol:ISR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
MOLOGEN AG (Symbol:MGN) SWOT Analysis, Strategy, Revenues and Profits

MOLOGEN AG (Symbol:MGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Germany
MorphoSys AG (Symbol:MOR) SWOT Analysis, Strategy, Revenues and Profits

MorphoSys AG (Symbol:MOR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
NanoViricides, Inc. (Symbol:NNVC) SWOT Analysis, Strategy, Revenues and Profits

NanoViricides, Inc. (Symbol:NNVC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Neovacs SA (Symbol:ALNEV) SWOT Analysis, Strategy, Revenues and Profits

Neovacs SA (Symbol:ALNEV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : France
Neuralstem, Inc. (Symbol:CUR) SWOT Analysis, Strategy, Revenues and Profits

Neuralstem, Inc. (Symbol:CUR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
NeuroMetrix, Inc. (Symbol:NURO) SWOT Analysis, Strategy, Revenues and Profits

NeuroMetrix, Inc. (Symbol:NURO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Medicure Inc. (MPH) - Financial and Strategic SWOT Analysis Review

Medicure Inc. (MPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Medicure Inc. (Medicure) is a pharmaceutical company. The company carries out research, clinical development and commercialization of human therapeutics. It offers products such as aggrastat and ...

  • Industries : Pathology
  • Countries : United States, Canada
NicOx S.A. (COX) - Financial and Strategic SWOT Analysis Review

NicOx S.A. (COX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary NicOx S.A. (NicOx) is a pharmaceutical company. It focuses on the development of ophthalmic portfolio of therapies and diagnostic tools. The company's products portfolio includes ophthalmic products ...

  • Industries : Pathology
  • Countries : France
Oscotec Inc. (Symbol:039200) SWOT Analysis, Strategy, Revenues and Profits

Oscotec Inc. (Symbol:039200) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : South Korea
OXiGENE, Inc. (Symbol:OXGN) SWOT Analysis, Strategy, Revenues and Profits

OXiGENE, Inc. (Symbol:OXGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
PHARMENA SA (Symbol:PHR) SWOT Analysis, Strategy, Revenues and Profits

PHARMENA SA (Symbol:PHR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Poland, United States
PhotoMedex, Inc. (Symbol:PHMD) SWOT Analysis, Strategy, Revenues and Profits

PhotoMedex, Inc. (Symbol:PHMD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
PhytoHealth Corporation (Symbol:4108) SWOT Analysis, Strategy, Revenues and Profits

PhytoHealth Corporation (Symbol:4108) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Taiwan
Prana Biotechnology Limited (Symbol:PBT) SWOT Analysis, Strategy, Revenues and Profits

Prana Biotechnology Limited (Symbol:PBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
PuraMed BioScience Inc. (Symbol:PMBS) SWOT Analysis, Strategy, Revenues and Profits

PuraMed BioScience Inc. (Symbol:PMBS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
R-Tech Ueno, Ltd. (Symbol:4573) SWOT Analysis, Strategy, Revenues and Profits

R-Tech Ueno, Ltd. (Symbol:4573) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Japan
Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Czech Republic, United States, Europe
Resverlogix Corp. (Symbol:RVX) SWOT Analysis, Strategy, Revenues and Profits

Resverlogix Corp. (Symbol:RVX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada, United States
Samjin Pharmaceutical Co., Ltd. (Symbol:005500) SWOT Analysis, Strategy, Revenues and Profits

Samjin Pharmaceutical Co., Ltd. (Symbol:005500) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : South Korea
Uroplasty, Inc. (Symbol:UPI) SWOT Analysis, Strategy, Revenues and Profits

Uroplasty, Inc. (Symbol:UPI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia, United States
Virax Holdings Limited (Symbol:VHL) SWOT Analysis, Strategy, Revenues and Profits

Virax Holdings Limited (Symbol:VHL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Welichem Biotech Inc. (Symbol:WBI) SWOT Analysis, Strategy, Revenues and Profits

Welichem Biotech Inc. (Symbol:WBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Chemed Corporation (Symbol:CHE) SWOT Analysis, Strategy, Revenues and Profits

Chemed Corporation (Symbol:CHE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States, Philippines, Singapore, Indonesia
About 33 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Industry - Company Report, January 2015

  • January 2015
    25 pages
  • Pathology  

    Pharmaceutical  

    General Medicin...  

  • United States  

    Japan  

    Europe  

View report >

About 200 Companies

Read our Company Profiles

Pfizer Inc.

United States

Imaging Systems L.L.C.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.